CHI3L1 and prostate cancer: Our team previously concluded that DAU inhibits macrophage M2 polarization through regulation of the PI3K/AKT signaling pathway and release of CHI3L1 from M2 macrophages, thus mitigating the malignant development of prostate cancer cells induced by M2 macrophages (Li et al. 2023).